HOUSTON, Sept. 3 US Oncology Specialty, LP, thestate-of-the-art pharmaceutical distribution center of US Oncology, hasreceived the Occupational Excellence Achievement Award from the NationalSafety Council for its outstanding safety achievements.
The award is presented to companies who produce the "best of the best" insafety and safety performance. To be eligible, organizations must report daysaway from work resulting from workplace injuries or illness at a rate equal toor less than 50 percent of the Bureau of Labor Statistics (BLS) rate for theirclassification code. The BLS rate for US Oncology Specialty's classificationcode is 0.9 percent; in order to qualify the organization had to report anincident rate of .45 percent or lower. In 2007, US Oncology Specialty,employing 32 employees, achieved a lost workday incidence rate of zeropercent.
US Oncology Specialty was launched in 2005 to manage the ordering anddelivery of approximately $1.8 billion of pharmaceuticals each year for itsaffiliated network of community-based oncologists. The organization hasfocused on ensuring the protection of employees and patients by investing insystems and security measures that produce results. The industry-leadingdistribution service was the first oncology distributor to achieve theNational Association of Boards of Pharmacy's (NABP) Verified-AccreditedWholesale Distributors (VAWD) accreditation to implement electronic pedigreetechnology, ensuring that pharmaceuticals are securely tracked, from themanufacturer to the patient, for optimum security and safety.
Additionally, the organization has twice received the OccupationalExcellence Award from the Texas chapter of the National Safety Council.
About US Oncology, Inc.
US Oncology, headquartered in Houston, works closely with physicians,manufacturers and payers to identify and deliver innovative services thatenhance patient access to advanced cancer care. US Oncology supports one ofthe nation's foremost cancer treatment and research networks accelerating theavailability and use of evidence-based medicine and shared best practices.
US Oncology's expertise in supporting every aspect of the cancer caredelivery system -- from drug development to treatment and outcomesmeasurement, enables the company to help increase the efficiency and safety ofcancer care. According to the company's last quarterly earnings report, USOncology is affiliated with 1,247 physicians operating in 472 locations,including 91 radiation oncology facilities in 39 states. For more information,visit the company's Web site, http://www.usoncology.com.
SOURCE US Oncology, Inc.